Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

1,263

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

September 30, 2011

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Placebo

Placebo, identical to Linagliptin tablet

DRUG

Linagliptin

intended final marketed dose

Trial Locations (169)

Unknown

1218.36.01043 Boehringer Ingelheim Investigational Site, Escondido

1218.36.01051 Boehringer Ingelheim Investigational Site, Escondido

1218.36.01065 Boehringer Ingelheim Investigational Site, Fresno

1218.36.01021 Boehringer Ingelheim Investigational Site, Greenbrae

1218.36.01013 Boehringer Ingelheim Investigational Site, Los Angeles

1218.36.01048 Boehringer Ingelheim Investigational Site, Los Angeles

1218.36.01058 Boehringer Ingelheim Investigational Site, San Diego

1218.36.01008 Boehringer Ingelheim Investigational Site, Santa Ana

1218.36.01056 Boehringer Ingelheim Investigational Site, Waterbury

1218.36.01054 Boehringer Ingelheim Investigational Site, Clearwater

1218.36.01035 Boehringer Ingelheim Investigational Site, Inverness

1218.36.01010 Boehringer Ingelheim Investigational Site, Miami

1218.36.01042 Boehringer Ingelheim Investigational Site, New Port Richey

1218.36.01063 Boehringer Ingelheim Investigational Site, Pembroke Pines

1218.36.01037 Boehringer Ingelheim Investigational Site, Ponte Vedra

1218.36.01032 Boehringer Ingelheim Investigational Site, Saint Cloud

1218.36.01049 Boehringer Ingelheim Investigational Site, St. Petersburg

1218.36.01036 Boehringer Ingelheim Investigational Site, Atlanta

1218.36.01047 Boehringer Ingelheim Investigational Site, Decatur

1218.36.01009 Boehringer Ingelheim Investigational Site, Roswell

1218.36.01055 Boehringer Ingelheim Investigational Site, Honolulu

1218.36.01014 Boehringer Ingelheim Investigational Site, Chicago

1218.36.01011 Boehringer Ingelheim Investigational Site, Paducah

1218.36.01034 Boehringer Ingelheim Investigational Site, City of Saint Peters

1218.36.01040 Boehringer Ingelheim Investigational Site, Kansas City

1218.36.01029 Boehringer Ingelheim Investigational Site, St Louis

1218.36.01018 Boehringer Ingelheim Investigational Site, Omaha

1218.36.01053 Boehringer Ingelheim Investigational Site, New Hartford

1218.36.01006 Boehringer Ingelheim Investigational Site, Burlington

1218.36.01025 Boehringer Ingelheim Investigational Site, Hickory

1218.36.01005 Boehringer Ingelheim Investigational Site, Statesville

1218.36.01015 Boehringer Ingelheim Investigational Site, Cincinnati

1218.36.01039 Boehringer Ingelheim Investigational Site, Tulsa

1218.36.01019 Boehringer Ingelheim Investigational Site, Altoona

1218.36.01012 Boehringer Ingelheim Investigational Site, Norristown

1218.36.01004 Boehringer Ingelheim Investigational Site, Greer

1218.36.01020 Boehringer Ingelheim Investigational Site, Simpsonville

1218.36.01003 Boehringer Ingelheim Investigational Site, Kingsport

1218.36.01038 Boehringer Ingelheim Investigational Site, Dallas

1218.36.01016 Boehringer Ingelheim Investigational Site, Houston

1218.36.01026 Boehringer Ingelheim Investigational Site, Salt Lake City

1218.36.01041 Boehringer Ingelheim Investigational Site, Bennington

1218.36.01064 Boehringer Ingelheim Investigational Site, Richmond

1218.36.01024 Boehringer Ingelheim Investigational Site, Lakewood

1218.36.01007 Boehringer Ingelheim Investigational Site, Renton

1218.36.01027 Boehringer Ingelheim Investigational Site, Spokane

1218.36.01062 Boehringer Ingelheim Investigational Site, Tacoma

1218.36.54001 Boehringer Ingelheim Investigational Site, Capital Federal

1218.36.54002 Boehringer Ingelheim Investigational Site, Capital Federal

1218.36.54003 Boehringer Ingelheim Investigational Site, Capital Federal

1218.36.54005 Boehringer Ingelheim Investigational Site, Capital Federal

1218.36.54004 Boehringer Ingelheim Investigational Site, Córdoba

1218.36.32002 Boehringer Ingelheim Investigational Site, Edegem

1218.36.320099 Boehringer Ingelheim Investigational Site, Edegem

1218.36.32006 Boehringer Ingelheim Investigational Site, Sint-Gillis-Waas

1218.36.55003 Boehringer Ingelheim Investigational Site, Belém

1218.36.55004 Boehringer Ingelheim Investigational Site, Porto Alegre

1218.36.55001 Boehringer Ingelheim Investigational Site, São Paulo

1218.36.55002 Boehringer Ingelheim Investigational Site, São Paulo

1218.36.02010 Boehringer Ingelheim Investigational Site, Calgary

1218.36.02004 Boehringer Ingelheim Investigational Site, Vancouver

1218.36.02011 Boehringer Ingelheim Investigational Site, Victoria

1218.36.02006 Boehringer Ingelheim Investigational Site, St. John's

1218.36.02002 Boehringer Ingelheim Investigational Site, Halifax

1218.36.02009 Boehringer Ingelheim Investigational Site, Hamilton

1218.36.02005 Boehringer Ingelheim Investigational Site, Kingston

1218.36.02008 Boehringer Ingelheim Investigational Site, Sarnia

1218.36.02007 Boehringer Ingelheim Investigational Site, Toronto

1218.36.02001 Boehringer Ingelheim Investigational Site, Laval

1218.36.02003 Boehringer Ingelheim Investigational Site, Montreal

1218.36.42004 Boehringer Ingelheim Investigational Site, Brno

1218.36.42006 Boehringer Ingelheim Investigational Site, Břeclav

1218.36.42005 Boehringer Ingelheim Investigational Site, Hodonín

1218.36.42002 Boehringer Ingelheim Investigational Site, Mladá Boleslav

1218.36.42001 Boehringer Ingelheim Investigational Site, Neratovice

1218.36.42007 Boehringer Ingelheim Investigational Site, Zlín

1218.36.35807 Boehringer Ingelheim Investigational Site, Joensuu

1218.36.35802 Boehringer Ingelheim Investigational Site, Kuopio

1218.36.35803 Boehringer Ingelheim Investigational Site, Oulu

1218.36.35805 Boehringer Ingelheim Investigational Site, Tampere

1218.36.35804 Boehringer Ingelheim Investigational Site, Turku

1218.36.35806 Boehringer Ingelheim Investigational Site, Vantaa

1218.36.49001 Boehringer Ingelheim Investigational Site, Berlin

1218.36.49002 Boehringer Ingelheim Investigational Site, Berlin

1218.36.49010 Boehringer Ingelheim Investigational Site, Berlin

1218.36.49009 Boehringer Ingelheim Investigational Site, Bosenheim

1218.36.49017 Boehringer Ingelheim Investigational Site, Cologne

1218.36.49004 Boehringer Ingelheim Investigational Site, Dortmund

1218.36.49006 Boehringer Ingelheim Investigational Site, Dresden

1218.36.49012 Boehringer Ingelheim Investigational Site, Magdeburg

1218.36.49005 Boehringer Ingelheim Investigational Site, Mainz

1218.36.49018 Boehringer Ingelheim Investigational Site, Neuwied

1218.36.49008 Boehringer Ingelheim Investigational Site, Pirna

1218.36.49019 Boehringer Ingelheim Investigational Site, Sulzbach-Rosenberg

1218.36.49003 Boehringer Ingelheim Investigational Site, Unterschneidheim

1218.36.49011 Boehringer Ingelheim Investigational Site, Wangen

1218.36.49014 Boehringer Ingelheim Investigational Site, Wangen

1218.36.49015 Boehringer Ingelheim Investigational Site, Westerkappeln

1218.36.30003 Boehringer Ingelheim Investigational Site, Athens

1218.36.30007 Boehringer Ingelheim Investigational Site, Athens

1218.36.30010 Boehringer Ingelheim Investigational Site, Athens

1218.36.30011 Boehringer Ingelheim Investigational Site, Larissa

1218.36.30002 Boehringer Ingelheim Investigational Site, Nikaia

1218.36.30005 Boehringer Ingelheim Investigational Site, Thessaloniki

1218.36.39002 Boehringer Ingelheim Investigational Site, Ferrara

1218.36.39003 Boehringer Ingelheim Investigational Site, Ferrara

1218.36.39004 Boehringer Ingelheim Investigational Site, Genova

1218.36.39005 Boehringer Ingelheim Investigational Site, Milan

1218.36.39001 Boehringer Ingelheim Investigational Site, Pordenone

1218.36.39007 Boehringer Ingelheim Investigational Site, Siena

1218.36.39006 Boehringer Ingelheim Investigational Site, Syracuse

1218.36.52002 Boehringer Ingelheim Investigational Site, Pachuca

1218.36.52004 Boehringer Ingelheim Investigational Site, San Luis Potosí City

1218.36.52005 Boehringer Ingelheim Investigational Site, Tijuana

1218.36.31008 Boehringer Ingelheim Investigational Site, 's-Hertogenbosch

1218.36.31001 Boehringer Ingelheim Investigational Site, Almere Stad

1218.36.31006 Boehringer Ingelheim Investigational Site, Beek

1218.36.31002 Boehringer Ingelheim Investigational Site, Ewijk

1218.36.31004 Boehringer Ingelheim Investigational Site, Oude Pekela

1218.36.31007 Boehringer Ingelheim Investigational Site, Roelofarendsveen

1218.36.31005 Boehringer Ingelheim Investigational Site, Wildervank

1218.36.47002 Boehringer Ingelheim Investigational Site, Bergen

1218.36.47006 Boehringer Ingelheim Investigational Site, Elverum

1218.36.47005 Boehringer Ingelheim Investigational Site, Hamar

1218.36.47004 Boehringer Ingelheim Investigational Site, Oslo

1218.36.47001 Boehringer Ingelheim Investigational Site, Stavanger

1218.36.51003 Boehringer Ingelheim Investigational Site, Lima

1218.36.70002 Boehringer Ingelheim Investigational Site, Moscow

1218.36.70003 Boehringer Ingelheim Investigational Site, Moscow

1218.36.70005 Boehringer Ingelheim Investigational Site, Saint Petersburg

1218.36.70001 Boehringer Ingelheim Investigational Site, Samara

1218.36.70007 Boehringer Ingelheim Investigational Site, Smolensk

1218.36.70006 Boehringer Ingelheim Investigational Site, Yaroslavl

1218.36.42103 Boehringer Ingelheim Investigational Site, Banská Bystrica

1218.36.42101 Boehringer Ingelheim Investigational Site, Bratislava

1218.36.42102 Boehringer Ingelheim Investigational Site, Bratislava

1218.36.42104 Boehringer Ingelheim Investigational Site, Bratislava

1218.36.42105 Boehringer Ingelheim Investigational Site, Prešov

1218.36.42106 Boehringer Ingelheim Investigational Site, Trebišov

1218.36.82004 Boehringer Ingelheim Investigational Site, Daegu

1218.36.82009 Boehringer Ingelheim Investigational Site, Daegu

1218.36.82008 Boehringer Ingelheim Investigational Site, Incheon

1218.36.82007 Boehringer Ingelheim Investigational Site, Jeonju

1218.36.82001 Boehringer Ingelheim Investigational Site, Pusan

1218.36.82002 Boehringer Ingelheim Investigational Site, Seoul

1218.36.82003 Boehringer Ingelheim Investigational Site, Seoul

1218.36.82005 Boehringer Ingelheim Investigational Site, Seoul

1218.36.82006 Boehringer Ingelheim Investigational Site, Seoul

1218.36.82010 Boehringer Ingelheim Investigational Site, Suwon

1218.36.34002 Boehringer Ingelheim Investigational Site, Badia Del Vallés (Barcelona)

1218.36.34005 Boehringer Ingelheim Investigational Site, Barcelona

1218.36.34010 Boehringer Ingelheim Investigational Site, Barcelona

1218.36.34001 Boehringer Ingelheim Investigational Site, Bercelona

1218.36.34007 Boehringer Ingelheim Investigational Site, Borges Del Camp (Tarragona)

1218.36.34003 Boehringer Ingelheim Investigational Site, Centelles (Barcelona)

1218.36.34004 Boehringer Ingelheim Investigational Site, L'Hospitalet de Llobregat (Barcelona)

1218.36.34011 Boehringer Ingelheim Investigational Site, Seville

1218.36.34009 Boehringer Ingelheim Investigational Site, Tàrrega (Lleida)

1218.36.34006 Boehringer Ingelheim Investigational Site, Vic (Barcelona)

1218.36.88610 Boehringer Ingelheim Investigational Site, Changhua

1218.36.88607 Boehringer Ingelheim Investigational Site, Kaohsiung City

1218.36.88601 Boehringer Ingelheim Investigational Site, Taichung

1218.36.88603 Boehringer Ingelheim Investigational Site, Taichung

1218.36.88606 Boehringer Ingelheim Investigational Site, Tainan City

1218.36.88602 Boehringer Ingelheim Investigational Site, Taipei

1218.36.88604 Boehringer Ingelheim Investigational Site, Taipei

1218.36.88605 Boehringer Ingelheim Investigational Site, Taipei

1218.36.88608 Boehringer Ingelheim Investigational Site, Taipei

1218.36.88609 Boehringer Ingelheim Investigational Site, Taipei

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY